Merxin Ltd
Merxin designs and supplies generic and customised inhaler device platforms, including multidose dry powder inhalers, capsule dry powder inhalers, soft mist inhalers, no heat no PG vaping devices and devices tailored to cannabinoid delivery to the lungs and nasal cavities.
Headquarters
Merxin Ltd
1 Innovation Drive
King’s Lynn
Norfolk
PE30 5BY
United Kingdom
Merxin Ltd designs and supplies generic and customised inhaler device platforms, including multidose dry powder inhalers, capsule dry powder inhalers, soft mist inhalers, no heat no PG vaping devices and devices tailored to cannabinoid delivery to the lungs and nasal cavities. Customers combine Merxin Ltd device platforms with their drug formulation to make final dosage forms that are supplied to users and patients.
The company has been assessed and certified as meeting the requirements of ISO 13485:2016 for the Design, Development and Supply of inhalers.
Merxin Ltd was established in the UK in 2015, is privately owned. It has manufacturing capacity across the globe, an international client base, and is adding more products to its portfolio as it expands rapidly.